Price $148.88 |
Market Cap
29.29B
|
Sector Health Care |
Div. Growth
10.70%
|
|
P/E
-
|
P/B
3.02
|
P/S
0.14
|
Dividend %
1.00%
|
|
P/CF
-
|
P/FCF
8.4
|
Op. Cash Flow
4.35M
|
FCF
16.8
|
|
Op. Margin
0.30%
|
Net Margin
-
|
ROE
0.60%
|
ROI
-1.00%
|
|
ROA
0.10%
|
EPS Growth
-98.60%
|
Current Ratio
1.0
|
Debt/Equity
68.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc (ARLZ) | $0.39 | - | - | 27.8M | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $14.86 | - | - | 44.2M | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.05 | - | - | 935.2M | Strong Buy |
| China Health Industries Holdin (CHHE) | $0.86 | - | - | 55.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
